Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, T-Cell

Explore clinical trials studying Lymphoma, T-Cell. Study availability and eligibility vary by location and protocol.

694 public trials 105 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, T-Cell trial results

Recruiting

Systemic Therapies in the Treatment of Cutaneous T-cell Lymphoma

NCT06588868

Conditions
Cutaneous T Cell Lymphoma, Cutaneous T-Cell Lymphoma/Mycosis Fungoides, Cutaneous T-Cell Lymphoma/Sezary Syndrome, +13 more
Locations
  • AOU Ospedali Riuniti delle Marche - Clinica di Ematologia Ancona, Italy
  • IRCCS Istituto Tumori Giovanni Paolo II - U.O.C. Ematologia Bari, Italy
  • U.O.C. Dermatologia e Venereologia Universitaria - A.O.U. Policlinico Consorziale Bari, Italy
  • Policlinico S.Orsola-Malpighi - Istituto di Ematologia Bologna, Italy
View all 18 locations
View Trial Details
Recruiting

DETERMINE Trial Treatment Arm 01: Alectinib in Adult, Paediatric and Teenage/Young Adult Patients With ALK Positive Cancers

NCT05770037

Conditions
Adenocarcinoma, Anaplastic Large Cell Lymphoma, Cancer, +37 more
Locations
  • Belfast City Hospital Belfast, United Kingdom
  • University Hospital Birmingham Birmingham, United Kingdom
  • Birmingham Children's Hospital Birmingham, United Kingdom
  • Bristol Royal Hospital for Children Bristol, United Kingdom
View all 27 locations
View Trial Details
Recruiting

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

NCT04094610

Conditions
Astrocytoma, Glioblastoma, Glioma, +30 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • University of California at Los Angeles Los Angeles, California, United States
  • Children's Hospital Colorado - Anschutz Medical Campus Aurora, Colorado, United States
  • Local Institution - 2105 Orlando, Florida, United States
View all 68 locations
View Trial Details
Recruiting

ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome

NCT02848274

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations
  • City of Hope Duarte, California, United States
  • Stanford University, School of Medicine Palo Alto, California, United States
  • University of Iowa Iowa City, Iowa, United States
  • Hackensack University Medical Center Hackensack, New Jersey, United States
View all 13 locations
View Trial Details
Recruiting

A Study of TLN-254 in Participants With Relapsed or Refractory T-cell Lymphoma

NCT06733441

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations
  • Stanford Cancer Institute Stanford, California, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
View Trial Details
Recruiting

CD30 CAR for Relapsed/Refractory CD30+ T Cell Lymphoma

NCT04083495

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Lineberger Comprehensive Cancer Center at University of North Carolina Chapel Hill, North Carolina, United States
  • Wake Forest Baptist Medical Center Winston-Salem, North Carolina, United States
View Trial Details

Related conditions